Article Information
History
- March 2, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Dalziza Victalina de Almeida1,*,
- Priscila Alves Cezar1,
- Thais Freitas Barreto Fernandes1,
- Marcos Gustavo Araujo Schwarz2,
- Leila Mendonça-Lima2,
- Carmem Beatriz Wagner Giacoia-Gripp1,
- Fernanda Heloise Côrtes1,
- Monick Lindenmeyer Guimarães1,
- Jose Henrique Pilotto1,
- Nathalia Beatriz Ramos de Sá1,
- Andressa da Silva Cazote1,
- Larissa Rodrigues Gomes3,
- Marcel de Souza Borges Quintana4,
- Marcelo Ribeiro-Alves5,
- Lara Coelho5,
- Kim Mattos Geraldo5,
- Maria Pia Diniz Ribeiro5,
- Sandra Wagner Cardoso5,
- Beatriz Gilda Jegerhom Grinsztejn5,
- Valdiléa Gonçalves Veloso dos Santos5 and
- Mariza Gonçalves Morgado1
- 1Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil
- 2Laboratory of Functional Genomics and Bioinformatics, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil
- 3Center of Technological Development in Health (CDTS)/National Institute of Science and Technological for Innovation on Neglected population diseases (INCT-IDPN), FIOCRUZ, Rio de Janeiro
- 4Clinical Research Platform, Evandro Chagas National Institute of Infectious Diseases, FIOCRUZ, Rio de Janeiro, RJ, Brazil
- 5Laboratory of Clinical Research on STD/AIDS, National Institute of Infectology Evandro Chagas, FIO-CRUZ, Rio de Janeiro
- ↵*Correspondence: Dalziza Victalina de Almeida - Address: Laboratory of AIDS & Molecular Immunology, Oswaldo Cruz Institute, FIOCRUZ. Av. Brazil 4365, Leonidas Deane Building, Room 401, Rio de Janeiro, Brazil. 21040-360 - E-mail: dalziza{at}gmail.com Tel: +55-21-38658227 - Fax: +55-21-38658173.
Posted March 02, 2023.
The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients
